Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Importation Safer Than Current System, Former FDAer Kessler Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Unregulated drug importation jeopardizes public health, former FDA Commissioner Kessler tells Senate Health Committee hearing, but regulated importation as proposed in bill by Sens. Dorgan and Snowe would provide "reasonable assurance that the drugs are safe and effective."

You may also be interested in...



Canada To Block U.S. Drug Importation With Legislative, Regulatory Actions

Health Canada plans to require an established physician-patient relationship before a U.S. prescription could be filled in a Canadian pharmacy. Health ministry will also introduce legislation prohibiting bulk exports to the U.S. Steps are pre-emptive strike against actions by states and legislation pending in Congress.

Canada To Block U.S. Drug Importation With Legislative, Regulatory Actions

Health Canada plans to require an established physician-patient relationship before a U.S. prescription could be filled in a Canadian pharmacy. Health ministry will also introduce legislation prohibiting bulk exports to the U.S. Steps are pre-emptive strike against actions by states and legislation pending in Congress.

Health Committee Hearings To Focus On HHS Importation Report

The committee will also hold hearings on the Dorgan/Snowe importation bill by the end of April. The legislation, which differs from legislation introduced by the senators last year, is backed by Finance Committee Chairman Grassley.

Topics

UsernamePublicRestriction

Register

OM010563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel